September 16, 2021
ROCKVILLE, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to […]
August 9, 2021
GBC Contributes to NCI – CPTAC Publication: A Proteogenomic Portrait of Lung Squamous Cell Carcinoma
Published in: CELL | VOLUME 184, ISSUE 16, P4348-4371.E40, AUGUST 05, 2021 Download: PDF [20 MB] Comprehensive proteogenomic characterization of lung squamous cell carcinomas and paired normal adjacent tissues […]
August 3, 2021
ROCKVILLE, Md., Aug. 03, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, […]
July 27, 2021
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel […]
July 8, 2021
The contract research sector has seen major buyouts and a series of bolt-on deals, and clinical research specialist WCG is the latest to get in on […]
July 8, 2021
The rumors were true: Whispers grew this year that Parexel, owned for the past four years by Pamplona Capital, was seeking a sale or an IPO. Today, […]
June 30, 2021
GAITHERSBURG, Md., June 30, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, […]
June 28, 2021
Surveys show patients, sponsors and CROs in Chinasee the benefits of virtual and hybrid trials. Concernsremain around regulatory gaps, digital data collectionand study logistics. View White […]
June 2, 2021
Posted 02 June 2021 | By Joanne S. Eglovitch The US Food and Drug Administration on 2 June authorized the marketing of a first-of-its kind device intended […]
